Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PTCTthis companyPTC Therapeutics, Inc.	$64.60	8.85×	-29.43×	3.49×	8.75×	-1377.4%	95.9%	49.5%	39.4%	-332.5%	33.4%	6.8%	-13.19×	1.94×	5.63×	2.35×	0.0%	4	0.75	2	C
BBIOBridgeBio Pharma, Inc.	$75.34	-20.18×	-7.27×	30.05×	-25.49×	-271.4%	94.4%	-113.3%	-145.3%	35.1%	-108.5%	-3.0%	-1.31×	-3.19×	-10.72×	2.62×	0.0%	2	-0.07	2	C
BMRNBioMarin Pharmaceutical Inc.	$56.07	32.65×	1.87×	3.54×	18.73×	-87.5%	77.1%	16.6%	10.8%	5.7%	5.6%	6.4%	0.11×	-1.17×	48.95×	5.21×	0.0%	3	0.33	3	B
CAPRCapricor Therapeutics, Inc.	$9.10	-12.77×	4.39×	0×	-10.7×	-20.2%	0.0%	0.0%	0.0%	-34.4%	-33.4%	-5.4%	0.06×	2.7×	-35.51×	9.01×	0.0%	2	0.16	2	C
DYNDyne Therapeutics, Inc.	$18.43	-5.64×	2.58×	0×	-3.74×	-61.0%	0.0%	0.0%	0.0%	-45.9%	-41.0%	-16.1%	0.02×	1.99×	-75.61×	22.25×	0.0%	2	3.6	2	C+
IONSIonis Pharmaceuticals, Inc.	$28.90	-33.24×	25.88×	13.41×	-52.41×	-292.2%	98.3%	-40.5%	-40.4%	-77.9%	-12.0%	-2.5%	5.35×	-7.89×	-4.22×	3.83×	0.0%	2	0.89	1	D+
Peer median	—	-12.77×	2.58×	3.54×	-10.7×	-87.5%	77.1%	0.0%	0.0%	-34.4%	-33.4%	-3.0%	0.06×	-1.17×	-10.72×	5.21×	0.0%	2	0.33	2	—